SSE: 2196 - Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Yield per half year: 0%
Dividend yield: +2.34%
Sector: Healthcare

Reporting Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Capitalization

IFRS
Reporting Annual
LTM 5 year average CAGR 5
Капитализация, млрд ¥
78.82
Выручка, млрд ¥
44.44
Чистая прибыль, млрд ¥
4.26
EV, млрд ¥
94.76
EBITDA, млрд ¥
5.9


Balance sheet

IFRS
Reporting Annual
LTM 5 year average CAGR 5
Наличность, млрд ¥
16.06
Долг, млрд ¥
30.78


Share

IFRS
Reporting Annual
LTM 5 year average CAGR 5
EPS 1.76


Efficiency

IFRS
Reporting Annual Quarterly
2023 2024 2025 LTM Industry average 5 year average CAGR 5
ROE, % 8.61 7.46
ROA, % 2.25 4.02
ROS, % 9.59 9.59 9.59 9.59 8.61 9.59 0.00
ROCE, % 0 0 0.00
Ebit margin, % 0 0
Рентаб EBITDA, % 13.28 13.28 -211.49 13.28 0.00
Чистая рентаб, % 9.59 8.61
Operation Margin, % 0 0 0 0 5.16


Coefficients

IFRS
Reporting Annual Quarterly
2023 2024 2025 LTM Industry average 5 year average CAGR 5
P/E
11.19 119.36
P/BV
1.07 3.78
P/S
1.08 13.31
P/FCF
0 0 0 0 -41.53
E/P
0.054 0.054 0.054 0.054 0.03 0.0540 0.00
EV/EBIT
0 0 0
EV/EBITDA
15.48 19.30
EV/S
2.13 2.13 2.13 2.13 43.18 2.13 0.00
EV/FCF
0 0 0 -45.85
Debt/EBITDA
5.22 5.22 5.22 5.22 1.87 5.22 0.00
Netdebt/Ebitda
0 0 0 0 0.24
Debt/Ratio
0 0 0 0 0.08
Debt/Equity
0 0 0 0 0.45
Debt/Net Income
7.23 7.23 7.23 7.23 3.11 7.23 0.00
PEG
0 0
Бета
0 0 0 0 0.29
Индекс Альтмана
0 0 0 0 5.11


Dividends

IFRS
Reporting Annual
LTM Industry average 5 year average CAGR 5
Дивиденд
0.46
Див доход, ао, %
2.34 0.81
Дивиденды / прибыль, %
34.8 69.64


Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

Subscribe

Other

IFRS
Reporting Annual
2023 CAGR 5
Персонал, чел
38399 0.00